Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford Medical Alumni Network

Sign up for mailings - keep in touch with medicine at Oxford.

Update your detailsMake sure you receive alumni news and event invitations.

Medical Sciences Division News

Seven Oxford researchers named NIHR Senior Investigators

Seven researchers from across Medical Sciences Division have been named among the latest cohort of National Institute for Health and Care Research (NIHR) Senior Investigators. This award recognises the most prominent and prestigious researchers of applied health and social care.

Student Prizes for Biomedical Sciences and Medicine 2025-2026

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2025-2026 academic year.

Blood test may improve survival of childhood cancer in Africa

A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.

GSK, University of Oxford and Imperial College London launch centre to create computer models of lungs, liver, kidneys and cartilage

A new research centre backed with £11 million from GSK will build open-source digital twins of organs for in-silico research to advance disease understanding and speed up development of new drugs.